The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β

References

• Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009; 27:519-50; PMID:19302047; http://dx.doi.org/10.1146/annurev.immunol.021908.132612
   PubMed Web of Science ®Google Scholar
• Dinarello CA, Simon A, van der Meer JWM. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discovery 2012; 11:633-52; PMID:22850787; http://dx.doi.org/10.1038/nrd3800
   PubMed Web of Science ®Google Scholar
• Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunology 2010; 10:89-102; PMID:20081871; http://dx.doi.org/10.1038/nri2691
   PubMed Web of Science ®Google Scholar
• Sims JE, Smith DE. Regulation of interleukin-1 activity is enhanced by cooperation between the interleukin-1 receptor type II and interleukin-1 receptor accessory protein. Eur Cytokine Netw 2003; 14:77-81; PMID:12957787
   PubMed Web of Science ®Google Scholar
• Priestle JP, Schär HP, Grütter MG. Crystallographic refinement of interleukin 1 beta at 2.0 A resolution. Proc Natl Acad Sci U S A 1989; 86:9667-71; PMID:2602367; http://dx.doi.org/10.1073/pnas.86.24.9667
   PubMed Web of Science ®Google Scholar
• Schreuder HA, Rondeau JM, Tardif C, Soffientini A, Sarubbi E, Akeson A, Bowlin TL, Yanofsky S, Barrett RW. Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline. Eur J Biochem 1995; 227:838-47; PMID:7867645; http://dx.doi.org/10.1111/j.1432-1033.1995.tb20209.x
   PubMedGoogle Scholar
• Vigers GP, Anderson LJ, Caffes P, Brandhuber BJ. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta. Nature 1997; 386:190-4; PMID:9062193; http://dx.doi.org/10.1038/386190a0
   PubMed Web of Science ®Google Scholar
• Thomas C, Bazan JF, Garcia KC. Structure of the activating IL-1 receptor signaling complex. Nat Struct Mol Biol 2012; 19:455-7; PMID:22426547; http://dx.doi.org/10.1038/nsmb.2260
   PubMed Web of Science ®Google Scholar
• Wang D, Zhang S, Li L, Liu X, Mei K, Wang X. Structural insights into the assembly and activation of IL-1β with its receptors. Nat Immunology 2010; 11:905-11; http://dx.doi.org/10.1038/ni.1925
   PubMed Web of Science ®Google Scholar
• Alten R, Gram H, Joosten LA, van den Berg WB, Sieper J, Wassenberg S, Burmester G, van Riel P, Diaz-Lorente M, Bruin GJM, et al. The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Res Ther 2008; 10:R67; PMID:18534016; http://dx.doi.org/10.1186/ar2438
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, Gitton X, Widmer A, Patel N, Hawkins PN. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009; 360:2416-25; PMID:19494217; http://dx.doi.org/10.1056/NEJMoa0810787
   PubMed Web of Science ®Google Scholar
• Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med 2012; 367:2396-406; PMID:23252526; http://dx.doi.org/10.1056/NEJMoa1205099
   PubMed Web of Science ®Google Scholar
• Schlesinger N, Alten RE, Bardin T, Schumacher HR, Bloch M, Gimona A, Krammer G, Murphy V, Richard D, So AK. Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann Rheum Dis 2012; 71:1839-48; PMID:22586173; http://dx.doi.org/10.1136/annrheumdis-2011-200908
   PubMed Web of Science ®Google Scholar
• Blech M, Peter D, Fischer P, Bauer MMT, Hafner M, Zeeb M, Nar H. One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1β. J Mol Biol 2013; 425:94-111; PMID:23041424; http://dx.doi.org/10.1016/j.jmb.2012.09.021
   PubMed Web of Science ®Google Scholar
• Lefranc MP. Nomenclature of the human immunoglobulin kappa (IGK) genes. Exp Clin Immunogenet 2001; 18:161-74; PMID:11549845; http://dx.doi.org/10.1159/000049195
   PubMedGoogle Scholar
• Pallarès N, Lefebvre S, Contet V, Matsuda F, Lefranc MP. The human immunoglobulin heavy variable genes. Exp Clin Immunogenet 1999; 16:36-60; PMID:Can't; http://dx.doi.org/10.1159/000019095
   PubMedGoogle Scholar
• Al-Lazikani B, Lesk AM, Chothia C. Standard conformations for the canonical structures of immunoglobulins. J Mol Biol 1997; 273:927-48; PMID:9367782; http://dx.doi.org/10.1006/jmbi.1997.1354
   PubMed Web of Science ®Google Scholar
• Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of proteins of immunological interest, 5th edit., NIH Publication no. 91-3242. Washington DC: US Department of Health and Human Services; 1991.
   Google Scholar
• Morea V, Tramontano A, Rustici M, Chothia C, Lesk AM. Conformations of the third hypervariable region in the VH domain of immunoglobulins. J Mol Biol 1998; 275:269-94; PMID:9466909; http://dx.doi.org/10.1006/jmbi.1997.1442
   PubMed Web of Science ®Google Scholar
• Lawrence MC, Colman PM. Shape complementarity at protein-protein interfaces. J Mol Biol 1993; 234:946-50; PMID:8263940; http://dx.doi.org/10.1006/jmbi.1993.1648
   PubMed Web of Science ®Google Scholar
• Wedemayer GJ, Patten PA, Wang LH, Schultz PG, Stevens RC. Structural insights into the evolution of an antibody combining site. Science 1997; 276:1665-9; PMID:9180069; http://dx.doi.org/10.1126/science.276.5319.1665
   PubMed Web of Science ®Google Scholar
• Lo Conte L, Janin J, Chothia C. The structure of protein-protein recognition sites. J Biol Chem 1990; 265:16027-30; PMID:2204619
   PubMed Web of Science ®Google Scholar
• Bhat TN, Bentley GA, Boulot G, Greene MI, Tello D, Dall'Acqua W, Souchon H, Schwarz FP, Mariuzza RA, Poljak RJ. Bound water molecules and conformational stabilization help mediate an antigen-antibody association. Proc Natl Acad Sci U S A 1994; 91:1089-93; PMID:8302837; http://dx.doi.org/10.1073/pnas.91.3.1089
   PubMed Web of Science ®Google Scholar
• Van Oostrum J, Priestle JP, Grutter MG, Schmitz A. The structure of murine interleukin-1beta at 2.8 Å resolution. J Struct Biol 1991; 107:189-95; PMID:1807351; http://dx.doi.org/10.1016/1047-8477(91)90021-N
   PubMed Web of Science ®Google Scholar
• Ohlendorf DH, Treharne AC, Weber PC, Wendoloski JJ, Salemme FR. A comparison of the high resolution structures of human and murine interleukin-1beta. RCSB PDB 1992; entry 8I1B; http://www.ncbi.nlm.nih.gov/Structure/mmdb/mmdbsrv.cgi?uid=58606
   Google Scholar
• Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallogr Sect A Found Crystallogr 1994; 50:157-63; http://dx.doi.org/10.1107/S0108767393007597
   Web of Science ®Google Scholar
• Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 1998; 54:905-21; PMID:9757107; http://dx.doi.org/10.1107/S0907444998003254
   PubMed Web of Science ®Google Scholar
• Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr Sect A Found Crystallogr 1991; 47: 110-9; http://dx.doi.org/10.1107/S0108767390010224
   PubMed Web of Science ®Google Scholar
• Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzym 1997; 276:307-26; http://dx.doi.org/10.1016/S0076-6879(97)76066-X
   PubMed Web of Science ®Google Scholar
• McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystallogr 2007; 40:658-74; PMID:19461840; http://dx.doi.org/10.1107/S0021889807021206
   PubMed Web of Science ®Google Scholar
• Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr Sect D Biol Crystallogr 2010; 66:486-501; http://dx.doi.org/10.1107/S0907444910007493
   PubMed Web of Science ®Google Scholar
• Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AGW, McCoy A, et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. Sect. D Biol. Crystallogr. 2011; 67:235-42; http://dx.doi.org/10.1107/S0907444910045749
   PubMed Web of Science ®Google Scholar